VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells
Mark A. Currier(Nationwide Children's Hospital), Timothy P. Cripe(Nationwide Children's Hospital), Keri A. Streby(Nationwide Children's Hospital), Louis Boon, Balveen Kaur(Augusta University), William F. Goins(University of Pittsburgh), Artur Chernoguz(Cincinnati Children's Hospital Medical Center), Allyson Sholl(Cincinnati Children's Hospital Medical Center), Margaret H. Collins(Cincinnati Children's Hospital Medical Center), Amy Haseley(Neurological Surgery), David A. Hildeman(University of Cincinnati Medical Center), Jennifer L. Leddon(University of Cincinnati), Pin-Yi Wang(Nationwide Children's Hospital), Brett W. Hendrickson(Nationwide Children's Hospital), Rolf A. Brekken(Southwestern Medical Center), Kelly Crawford(Cincinnati Children's Hospital Medical Center), William H. Baird(Cincinnati Children's Hospital Medical Center), Jason S. Frischer, Francis K. Eshun(Cincinnati Children's Hospital Medical Center), Senad Divanovic(Cincinnati Children's Hospital Medical Center)
Cited by 40
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452